Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis (UCanADA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02506179
Recruitment Status : Completed
First Posted : July 23, 2015
Last Update Posted : January 25, 2021
Cato Research
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 10, 2020
Actual Study Completion Date : February 10, 2020